Compass Pathways to join Stifel healthcare conference

Compass Pathways plc said its management will attend the Stifel 2026 Healthcare Conference on November 11 and take part in a fireside chat at 8:40 a.m. ET.

The biotechnology company said a live audio webcast of the session will be available, with a replay accessible for 30 days through the events page in the investors section of its website.

Compass Pathways said its work focuses on mental health treatments, including COMP360 psilocybin, an investigational synthetic psilocybin treatment under evaluation for treatment-resistant depression and post-traumatic stress disorder. The company is headquartered in London and has a US office in New Jersey.